Seven Pediatric Risks Adult-Focused Digital-Health Teams Commonly Miss
Most digital-health products are designed for adults first. When the same product is used for children — or by the parents and carers acting for them — assumptions that were harmless in an adult context quietly become safety risks. Teams that have never built for paediatrics rarely spot these on their own, because the gaps sit in clinical knowledge they do not know they are missing.
This article sets out seven pediatric risks that adult-focused teams commonly miss, with practical checks for each. It is written from the perspective of a pediatrician by training, for founders, product managers and developers whose products touch children or families.
In this article
- 1. Weight-based dosing language
- 2. Age cut-offs that do not match clinical reality
- 3. Consent, privacy and who the user actually is
- 4. Growth, development and age-normed references
- 5. Adult-trained symptom logic applied to children
- 6. Communication that frightens or confuses families
- 7. Safeguarding and escalation for vulnerable children
- FAQ
1. Weight-based dosing language
Adult dosing is usually one tablet, twice daily. Paediatric dosing is milligrams per kilogram — and it changes as the child grows. Products built for adults routinely present doses as fixed amounts, or show a single “child dose” as if children were one size. Both are dangerous: a dose that is right for a ten-year-old can be an overdose for a toddler.
Check every place your product mentions a dose, a quantity or a measurement: does it ask for the child’s weight, does it state the units unambiguously, and does it make clear that doses must be confirmed with a clinician or pharmacist? If your product avoids dosing entirely, say so explicitly rather than leaving users to guess.
2. Age cut-offs that do not match clinical reality
Adult products love clean thresholds: over 18, under 65. Paediatrics does not work that way. A newborn, a toddler, a school-age child and an adolescent are clinically different populations, and the boundaries between them vary by condition and by guideline. A product that treats everyone under 18 as one group will be wrong for most of them, most of the time.
Review every age threshold in your product — content, logic, eligibility, warnings — and check each one against a clinical source. Pay special attention to adolescents: they are often legally and developmentally distinct from younger children, and products that lump them with toddlers fail both groups.
3. Consent, privacy and who the user actually is
In adult products, the user and the patient are the same person. In paediatrics, they often are not: a parent books, a child is treated; a teenager uses the app, a parent pays. Products that assume one user identity create consent and privacy problems — health information shown to the wrong person, or a child unable to access their own care information.
Map out who can see what, for every screen. Who consents to what, and at what age does that change? How does the product handle the transition when a child becomes old enough to manage their own care? These are product-design questions with clinical and legal weight, and they need answers before launch, not after the first complaint.
4. Growth, development and age-normed references
“Normal” in paediatrics is a moving target. Heart rate, blood pressure, developmental milestones, growth measurements — all are interpreted against age and sex norms, not fixed values. Adult-focused products that flag readings as high or low against adult ranges will generate false alarms for children, or worse, false reassurance.
Audit every reference range, threshold and milestone in your product. Each one should be traceable to a paediatric source, with the age range it applies to stated alongside it. If a measurement cannot be interpreted without knowing the child’s age, the product should require the age before showing an interpretation.
5. Adult-trained symptom logic applied to children
Children are not small adults: they present differently, deteriorate faster, and cannot always describe what is wrong. Symptom checkers and triage logic trained on adult presentations miss paediatric red flags — a fever that is routine in an adult can be an emergency in a neonate, and serious illness in children can present with vague symptoms like poor feeding or unusual sleepiness.
If your product includes any symptom assessment, chatbot triage or “is this urgent” logic, it needs a paediatric pathway built with paediatric input — not an adult pathway with the thresholds tweaked. The ten clinical-safety checks for healthcare chatbots apply here with extra force, particularly the red-flag handling.
6. Communication that frightens or confuses families
The audience for paediatric content is usually a worried parent, often reading at 2am. Adult-focused teams write in a register that is either too clinical (“febrile seizure” with no explanation) or too alarming (worst-case scenarios presented without context or probability). Both drive poor decisions: panic, or the opposite — a parent reassured by jargon they did not understand.
Review parent-facing content for plain language, calm tone and clear next steps. Every piece of paediatric content should answer three questions: what is happening, what should I do now, and when should I worry. For a structured method, see how to evaluate AI-generated patient instructions — the same checks apply, with families as the audience.
7. Safeguarding and escalation for vulnerable children
Adult products rarely consider that a user might be a child at risk. Paediatric products must. Consider: what does the product do if a child discloses harm, if a parent’s messages suggest neglect, or if usage patterns raise concern? “Nothing — that’s not our job” is not an acceptable answer when children are the users.
Build a safeguarding pathway with professional input: how concerns are recognised, who reviews them, how quickly, and what the escalation routes are in each market you serve. Train the team that monitors the product. Document it. This is the risk adult-focused teams miss most completely, and the one with the gravest consequences.
FAQ
Why can’t we just adapt our adult product for children?
Because the clinical assumptions differ at every level: dosing, reference ranges, symptom presentation, consent, communication and safeguarding. Adapting an adult product usually means carrying adult assumptions into paediatric contexts, where they become risks. Paediatric use needs its own clinical review.
What is the most common pediatric content mistake?
Presenting adult reference ranges, doses or thresholds as if they applied to children — or presenting a single “child” value as if all children were the same. Every paediatric number needs an age range and a paediatric source.
Do we need a pediatrician to review family-facing content?
Yes. Paediatric content reviewed only by adult clinicians — or by no clinician — is where most of these risks originate. A paediatric review before launch, and a defined review process afterwards, is the standard to aim for.
How should dosing information be presented for children?
With the weight the dose is based on, unambiguous units, and a clear statement that doses must be confirmed with a clinician or pharmacist. If your product is not the right place for dosing information, say so rather than showing a simplified version.
What is safeguarding in a digital-health context?
The set of processes that protect children using your product from harm: recognising disclosures or signs of abuse and neglect, reviewing them promptly with trained staff, and escalating through the proper channels. Every paediatric product needs a documented safeguarding pathway.
Building a healthcare-AI or pediatric digital-health product? DigitalProved provides an independent review of clinical content, patient-safety risks, escalation advice and user communication — handled entirely by email, no calls needed. Write to support@digitalproved.com to request a review.
